Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.

Michael D. Prados; Michael McDermott; Susan M. Chang; Charles B. Wilson; James Fick; Kenneth W. Culver; John Van Gilder; G. Evren Keles; Alex Spence; Mitchel Berger

doi:10.1023/B:NEON.0000003588.18644.9C

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.

Michael D. Prados, Michael McDermott, Susan M. Chang, Charles B. Wilson, James Fick, Kenneth W. Culver, John Van Gilder, G. Evren Keles, Alex Spence, Mitchel Berger

Miami Neuroscience Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	65
DOIs	https://doi.org/10.1023/B:NEON.0000003588.18644.9C
State	Published - Dec 1 2003

Disciplines

Gastroenterology
Medicine and Health Sciences
Surgery
Internal Medicine

Access to Document

10.1023/B:NEON.0000003588.18644.9CLicense: Unspecified

Cite this

Prados, M. D., McDermott, M., Chang, S. M., Wilson, C. B., Fick, J., Culver, K. W., Van Gilder, J., Keles, G. E., Spence, A., & Berger, M. (2003). Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. Journal of neuro-oncology, 65. https://doi.org/10.1023/B:NEON.0000003588.18644.9C

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. / Prados, Michael D.; McDermott, Michael; Chang, Susan M. et al.
In: Journal of neuro-oncology, Vol. 65, 01.12.2003.

Research output: Contribution to journal › Article › peer-review

Prados, MD, McDermott, M, Chang, SM, Wilson, CB, Fick, J, Culver, KW, Van Gilder, J, Keles, GE, Spence, A & Berger, M 2003, 'Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.', Journal of neuro-oncology, vol. 65. https://doi.org/10.1023/B:NEON.0000003588.18644.9C

Prados MD, McDermott M, Chang SM, Wilson CB, Fick J, Culver KW et al. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. Journal of neuro-oncology. 2003 Dec 1;65. doi: 10.1023/B:NEON.0000003588.18644.9C

@article{64e4c33b02754193be25db15074f0673,

title = "Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.",

author = "Prados, {Michael D.} and Michael McDermott and Chang, {Susan M.} and Wilson, {Charles B.} and James Fick and Culver, {Kenneth W.} and {Van Gilder}, John and Keles, {G. Evren} and Alex Spence and Mitchel Berger",

note = "To determine the safety and evaluate the efficacy of repeated administration of virus-producing cells (GLI 328) containing the herpes simplex virus thymidine-kinase gene followed by ganciclovir treatment in adults with recurrent glioblastoma multiforme, we conducted a phase I/II multi-institutional ...",

year = "2003",

month = dec,

day = "1",

doi = "10.1023/B:NEON.0000003588.18644.9C",

language = "American English",

volume = "65",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.

AU - Prados, Michael D.

AU - McDermott, Michael

AU - Chang, Susan M.

AU - Wilson, Charles B.

AU - Fick, James

AU - Culver, Kenneth W.

AU - Van Gilder, John

AU - Keles, G. Evren

AU - Spence, Alex

AU - Berger, Mitchel

N1 - To determine the safety and evaluate the efficacy of repeated administration of virus-producing cells (GLI 328) containing the herpes simplex virus thymidine-kinase gene followed by ganciclovir treatment in adults with recurrent glioblastoma multiforme, we conducted a phase I/II multi-institutional ...

PY - 2003/12/1

Y1 - 2003/12/1

UR - http://www.ncbi.nlm.nih.gov/pubmed/14682377

U2 - 10.1023/B:NEON.0000003588.18644.9C

DO - 10.1023/B:NEON.0000003588.18644.9C

M3 - Article

VL - 65

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.

Disciplines

Access to Document

Other files and links

Cite this